Generated with Avocode.Line 2Line 3
Video: Volumetric AI-driven measurement represents the future of aneurysm management
View Recording
ISC 2023: February 8-10 in Dallas Stop by and see us at Booth #705
Schedule a Meeting
Customer Support
Contact

RapidAI Aneurysm

Comprehensive Aneurysm Management

Rapid Aneurysm is an FDA-cleared imaging platform for cerebral aneurysm management. Helping physicians save time, improve patient care, and increase patient volume by accelerating the process of finding, tracking, and proactively treating aneurysms.

Find, track, treat

Improve Aneurysm Surveillance

Rapid Aneurysm addresses the need for physicians to find, track, and proactively treat
aneurysms using accurate data within one intuitive system. From a patient’s imaging scans, the platform creates a personalized 3D model of the vasculature and provides tools for accurate measurement and identification of morphological changes.

Converts 2D images to 3D vasculature models to aid in the visibility of aneurysms

Highlights Potential Aneurysms
Calculates and Records Clinically
Relevant Measurements

Provides high-resolution measurement tools to help clinicians more precisely measure and visualize morphological changes

Consecutive Scans
Compares Measurements
Compares Morphology
KEY BENEFITS
IMPROVE PATIENT CARE

Improve patient care by finding and more accurately measuring aneurysms which may have gone undetected.

SAVE TIME

Save time using seamlessly converted 2D images to 3D vasculature models that accelerate the aneurysm workflow and help physicians make informed intervention decisions.

INCREASE PATIENT VOLUME

Increase patient volume and keep patients within your network for further imaging, tracking and treatment.

“A well-validated AI programme [Rapid Aneurysm] that detects cerebral aneurysms is expected to be an asset to radiologists. AI programmes that detect cerebral aneurysms on CTA have been shown to improve radiologists’ sensitivity for the detection of aneurysms.”

Dr. Jeremy Heit, MD
Interventional Neuroradiologist Stanford University

"Artificial intelligence aneurysm measurement tool [Rapid Aneurysm] finds growth in all aneurysms that ruptured during conservative management."

Daniel H. Sahlein MD
Director of Stroke at Ascension St. Vincent’s Indianapolis

Rapid Research Series

Volumetric AI-driven measurement represents the future of aneurysm management

View Webinar Recording

Rapid Research Series

Imaging platform to visualize and find unruptured brain aneurysms in CTA scans

See Study Summary
SCHEDULE AN ROI ANALYSIS

See the upside in time savings and revenue for your practice

Talk to an Expert
RapidAIlogo
The Next Evolution in Clinical Decision Making and Patient Workflow

Subscribe to our Newsletter

Follow us on social:

Products and Solutions

Company

News & Events

® RapidAI and Rapid are registered trademarks of iSchemaView, Inc. | Privacy Policy